— News and commentary from the endocrinology world
June 16, 2026
• 2 min read
A massive wave of new prescriptions for GLP-1 receptor agonists is expected following the July launch of a Medicare pilot program that offers the drugs for weight loss for a flat $50 monthly copay. (Axios)
Meanwhile, nearly 80% of employers said GLP-1 medications are driving an increase in their healthcare costs, and some may drop coverage next year, a Business Group on Health survey found.
